Profile
Yuan Wen is the founder.
She founded Shenzhen Haplox Biotechnology Co., Ltd.
in 2014 and HaploX Investment Holding Ltd.
in 2021, where she held the title of Executive Director & GM-Supply Chain.
Ms. Wen has a graduate degree from The University of New Mexico, which she received in 2013, and an undergraduate degree from Renmin University of China, which she received in 2005.
Former positions of Yuan Wen
| Companies | Position | End |
|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Founder | - |
Shenzhen Haplox Biotechnology Co., Ltd.
 Shenzhen Haplox Biotechnology Co., Ltd. BiotechnologyHealth Technology Shenzhen Haplox Biotechnology Co. Ltd. develops clinical application device which helps to detect cancer tumour. The firm’s products cover cancer early screening, individualized drug guidance, prognosis monitoring, drug resistance assessment and provide precision cancer health care for the patients. The company was founded by Shi Fu Chen, Wen Fang, Yuan Wen and Ming Yan Xu on September 12, 2014 and is headquartered in Shenzhen, China. | Founder | - |
Training of Yuan Wen
| Renmin University of China | Undergraduate Degree |
| The University of New Mexico | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Shenzhen Haplox Biotechnology Co., Ltd.
Shenzhen Haplox Biotechnology Co., Ltd. BiotechnologyHealth Technology Shenzhen Haplox Biotechnology Co. Ltd. develops clinical application device which helps to detect cancer tumour. The firm’s products cover cancer early screening, individualized drug guidance, prognosis monitoring, drug resistance assessment and provide precision cancer health care for the patients. The company was founded by Shi Fu Chen, Wen Fang, Yuan Wen and Ming Yan Xu on September 12, 2014 and is headquartered in Shenzhen, China. | Health Technology |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Stock Market
- Insiders
- Yuan Wen
